A national pharmacovigilance study of haematological adverse drug reactions to clozapine vs other second-generation antipsychotics in Italy

Schizophr Res. 2023 Jul:257:25-26. doi: 10.1016/j.schres.2023.05.009. Epub 2023 May 25.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antipsychotic Agents* / adverse effects
  • Clozapine* / adverse effects
  • Drug-Related Side Effects and Adverse Reactions*
  • Humans
  • Italy
  • Olanzapine
  • Pharmacovigilance

Substances

  • Antipsychotic Agents
  • Clozapine
  • Olanzapine